Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02166762 · ClinicalTrials.gov registry record · NA
Correlating QLV Interval to Left Ventricular (LV) Lead Position in Patients Receiving Cardiac Resynchronization Therapy.
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02166762 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 20 participants.
The verdict
NCT02166762, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a prospective clinical trial to determine the optimal QLV interval during implantation to achieve the best possible response from cardiac resynchronization therapy for heart failure patients.
Interventions
- PROCEDURE QLV interval measurement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-05 |
| Est. Completion | 2015-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02166762
The ClinicalTrials.gov registry entry for NCT02166762 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which QLV interval measurement is the first listed.
NCT02166762 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02166762 about?
NCT02166762 is a clinical study titled "Correlating QLV Interval to Left Ventricular (LV) Lead Position in Patients Receiving Cardiac Resynchronization Therapy.". This is a prospective clinical trial to determine the optimal QLV interval during implantation to achieve the best possible response from cardiac resynchronization therapy for heart failure patients.
What is the current status of trial NCT02166762?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2013-05. Estimated completion is 2015-09.
What interventions are being tested in trial NCT02166762?
The interventions under investigation include: QLV interval measurement (PROCEDURE).
Who is sponsoring clinical trial NCT02166762?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.